Harbour Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457 | Hold |
51
| – | – | ﹤0.01% | 3389 |
|
|
2025
Q1 | $383 | Hold |
51
| – | – | ﹤0.01% | 3368 |
|
|
2024
Q4 | $384 | Hold |
51
| – | – | ﹤0.01% | 3306 |
|
|
2024
Q3 | $388 | Hold |
51
| – | – | ﹤0.01% | 3219 |
|
|
2024
Q2 | $315 | Hold |
51
| – | – | ﹤0.01% | 3132 |
|
|
2024
Q1 | $259 | Hold |
51
| – | – | ﹤0.01% | 3092 |
|
|
2023
Q4 | $305 | Hold |
51
| – | – | ﹤0.01% | 2989 |
|
|
2023
Q3 | $361 | Hold |
51
| – | – | ﹤0.01% | 2835 |
|
|
2023
Q2 | $359 | Hold |
51
| – | – | ﹤0.01% | 2849 |
|
|
2023
Q1 | $425 | Hold |
51
| – | – | ﹤0.01% | 2825 |
|
|
2022
Q4 | $585 | Hold |
51
| – | – | ﹤0.01% | 2778 |
|
|
2022
Q3 | $1K | Hold |
51
| – | – | ﹤0.01% | 2540 |
|
|
2022
Q2 | $1K | Buy |
+51
| New | +$1K | ﹤0.01% | 2540 |
|
|
2021
Q4 | – | Sell |
-7
| Closed | – | – | 2708 |
|
|
2021
Q3 | $0 | Buy |
7
+2
| +40% | – | ﹤0.01% | 3732 |
|
|
2021
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 3767 |
|
|
2021
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 3595 |
|